Eli Lilly shares rise as Q3 revenue jumps 54% to $17.6 billion, earnings top estimates, and analysts lift price targets on ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

The drug, which Lilly in-licensed four years ago and is designed to inhibit a protein known as P2X7, did not meet the company ...

Through an exclusive partnership with Eli Lilly, the company has begun distributing and promoting Yurpeak (Tirzepatide) in ...

Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on ...

Shares of Danish rival Novo Nordisk slipped after it sought to snatch Pfizer target Metsera from the American drug giant's arms. Novo launched an unsolicited bid valued at up to $9 billion for obesity ...

Speedskater Erin Jackson spoke about living with eczema. By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as ...

The Hollywood star sat down with Newsweek to discuss his next big project: upping enrollment in clinical trials.

Lilly and NVIDIA’s supercomputer marks the world's first NVIDIA DGX SuperPOD with DGX B300 systems, and is powered by more than 1,000 B300 GPUs on a unified networking fabric, meaning communication ...

Pharma giant Eli Lilly tapped Walmart to offer in-store pickups of Zepbound vials, marking the first retail collaboration for ...

Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer recently provided insights on. Cramer highlighted it as the ...

The deal, which enables patients to pick up orders placed through Lilly’s online channel at Walmart pharmacies, is the latest ...